利用SAR302503克服FLT3-ITD的AC220耐药性。 - Suppr

Overcoming AC220 resistance of FLT3-ITD by SAR302503.

作者信息

Kesarwani M, Huber E, Azam M

机构信息

Cincinnati Children's Hospital Medical Center, Cancer Blood Disease Institute, Divisions of Experimental Hematology and Cancer Pathology, Cincinnati, OH, USA.

出版信息

Blood Cancer J. 2013 Aug 30;3(8):e138. doi: 10.1038/bcj.2013.40.

DOI:10.1038/bcj.2013.40

PMID:23995047

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3763391/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e17/3763391/8ce774fd1d76/bcj201340f1.jpg

相似文献

Overcoming AC220 resistance of FLT3-ITD by SAR302503.利用SAR302503克服FLT3-ITD的AC220耐药性。

Blood Cancer J. 2013 Aug 30;3(8):e138. doi: 10.1038/bcj.2013.40.

Novel AXL-targeted agents overcome FLT3 inhibitor resistance in FLT3-ITD acute myeloid leukemia cells.新型AXL靶向药物克服FLT3-ITD急性髓系白血病细胞中的FLT3抑制剂耐药性。

Oncol Lett. 2021 May;21(5):397. doi: 10.3892/ol.2021.12658. Epub 2021 Mar 18.

Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.FLT3的内部串联重复通过上调造血细胞中的RUNX1表达来解除增殖和分化的调控，并赋予对FLT3抑制剂AC220的抗性。

Int J Hematol. 2016 Jan;103(1):95-106. doi: 10.1007/s12185-015-1908-8. Epub 2015 Nov 21.

Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells.FLT3中的内部串联重复通过调节造血细胞中的p21Cdkn1a和Pbx1来减弱增殖并调节对FLT3抑制剂AC220的抗性。

PLoS One. 2016 Jul 7;11(7):e0158290. doi: 10.1371/journal.pone.0158290. eCollection 2016.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.FLT3 内部串联重复突变在人类急性髓系白血病治疗靶点中的验证。

Nature. 2012 Apr 15;485(7397):260-3. doi: 10.1038/nature11016.

Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.ponatinib 对具有临床相关性的 FLT3-ITD 激酶结构域突变体 AC220 耐药的抑制活性。

Blood. 2013 Apr 18;121(16):3165-71. doi: 10.1182/blood-2012-07-442871. Epub 2013 Feb 21.

[Effect of FLT3-ITD Length on 32D Cell Proliferation, Apoptosis and Sensitivity to FLT3 Inhibitor].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Aug;29(4):1034-1038. doi: 10.19746/j.cnki.issn.1009-2137.2021.04.004.

A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.一项全基因组CRISPR筛选确定了对FLT3抑制剂AC220耐药至关重要的基因。

Cancer Res. 2017 Aug 15;77(16):4402-4413. doi: 10.1158/0008-5472.CAN-16-1627. Epub 2017 Jun 16.

Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitors.组蛋白去乙酰化酶抑制剂 panobinostat 与 FLT3 特异性抑制剂联合作用导致 FLT3-ITD/STAT5 轴的崩溃和协同凋亡诱导。

Mol Cancer Ther. 2012 Nov;11(11):2373-83. doi: 10.1158/1535-7163.MCT-12-0129. Epub 2012 Aug 31.

Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.酪氨酸激酶抑制剂诱导的 DNA 修复缺陷使 FLT3(ITD)阳性白血病细胞对 PARP1 抑制剂敏感。

Blood. 2018 Jul 5;132(1):67-77. doi: 10.1182/blood-2018-02-834895. Epub 2018 May 21.

引用本文的文献

Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia.同时抑制p300/CBP和FLT3可增强急性髓系白血病的细胞毒性并克服耐药性。

Acta Pharmacol Sin. 2025 May;46(5):1390-1403. doi: 10.1038/s41401-025-01479-w. Epub 2025 Jan 30.

Targeting FLT3 Mutations in Acute Myeloid Leukemia.靶向急性髓系白血病中的FLT3突变

Cells. 2018 Jan 8;7(1):4. doi: 10.3390/cells7010004.

Mechanisms of Resistance to FLT3 Inhibitors and the Role of the Bone Marrow Microenvironment.FLT3抑制剂耐药机制及骨髓微环境的作用

Hematol Oncol Clin North Am. 2017 Aug;31(4):681-692. doi: 10.1016/j.hoc.2017.04.005. Epub 2017 May 18.

A method for screening and validation of resistant mutations against kinase inhibitors.一种针对激酶抑制剂的抗性突变的筛选和验证方法。

J Vis Exp. 2014 Dec 7(94):51984. doi: 10.3791/51984.

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.STAT3 信号在前列腺癌进展中的多方面作用。

Cancers (Basel). 2014 Apr 9;6(2):829-59. doi: 10.3390/cancers6020829.

本文引用的文献

Blood. 2013 Apr 18;121(16):3165-71. doi: 10.1182/blood-2012-07-442871. Epub 2013 Feb 21.

Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors.FLT3/ITD 突变赋予对多种酪氨酸激酶抑制剂的耐药性。

Leukemia. 2013 Jan;27(1):48-55. doi: 10.1038/leu.2012.191. Epub 2012 Jul 13.

FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia.FLT3 抑制：急性髓系白血病中不断变化的治疗靶点。

Leukemia. 2013 Feb;27(2):260-8. doi: 10.1038/leu.2012.195. Epub 2012 Jul 16.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.FLT3 内部串联重复突变在人类急性髓系白血病治疗靶点中的验证。

Nature. 2012 Apr 15;485(7397):260-3. doi: 10.1038/nature11016.

Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.索拉非尼治疗 FLT3-ITD(+) 急性髓系白血病：有利的初始结果和随后无反应的机制与 D835 突变的出现有关。

Blood. 2012 May 31;119(22):5133-43. doi: 10.1182/blood-2011-06-363960. Epub 2012 Feb 24.

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis.选择性 JAK2 抑制剂 TG101348 治疗骨髓纤维化的安全性和疗效。

J Clin Oncol. 2011 Mar 1;29(7):789-96. doi: 10.1200/JCO.2010.32.8021. Epub 2011 Jan 10.

Activation of tyrosine kinases by mutation of the gatekeeper threonine.通过守门苏氨酸突变激活酪氨酸激酶。

Nat Struct Mol Biol. 2008 Oct;15(10):1109-18. doi: 10.1038/nsmb.1486. Epub 2008 Sep 14.

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.选择性JAK2抑制剂TG101348对JAK2V617F诱导的真性红细胞增多症小鼠模型的治疗效果。

Cancer Cell. 2008 Apr;13(4):311-20. doi: 10.1016/j.ccr.2008.02.009.

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.TG101209，一种小分子JAK2选择性激酶抑制剂，能有效抑制与骨髓增殖性疾病相关的JAK2V617F和MPLW515L/K突变。

Leukemia. 2007 Aug;21(8):1658-68. doi: 10.1038/sj.leu.2404750. Epub 2007 May 31.

Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.双重SRC-ABL抑制剂的活性凸显了BCR/ABL激酶动力学在耐药性中的作用。

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9244-9. doi: 10.1073/pnas.0600001103. Epub 2006 Jun 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Overcoming AC220 resistance of FLT3-ITD by SAR302503.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献